Improving quality of life
MAC CLINICAL RESEARCH
HOME
NEWS
RESOURCE LIBRARY
GMP PHARMACY
CAREERS
PATIENTS - JOIN A STUDY
ABOUT US
Dedicated Research Sites
Working with MAC
Leadership
Quality Assurance
Mission and Values
Our History
Healthcare Provision
News
SERVICES
CRO Solutions
Adaptive Trials
Clinical Trial Feasibility
Project Management
Phase 1 Clinical Trials
Sleep Laboratory
Pharmacodynamics
Hallucinogenic Compounds
Remote Clinical Trial Support
GMP Pharmacy
Regulatory Affairs
CLINICAL RESEARCH
MAC EnVision - Participant Recruitment
Participant Retention
Clinical Assessments
Placebo Response
CASE STUDIES
Case Studies
Timeline Recovery
CONTACT US
More
Use tab to navigate through the menu items.
Oct 23, 2018
CLINICAL TRIALS ON ALZHEIMER'S DISEASE 2018, BARCELONA
Back to News
Back to Resources
Featured Posts
MHRA approve launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of OUD
MAC Achieves Cyber Essentials Certification
HOT OFF THE PRESS!! - JOBS - CAREERS WITH MAC
PRESS RELEASE: MAC Clinical Research expands its Global Site Network and access to patients in Aust
MAC GMP Pharmacy Manufacturing Service - Pharmacy MIA(IMP) Licenced Production Unit
Defying Dementia - Help the fight against dementia
Dr Mark Dale Receives Honorary Membership of the Faculty of Pharmaceutical Medicine
PRESS RELEASE: MHRA Award Accreditation for MAC's Phase 1 Site
New Alzheimer's Drug to Enter Clinical Trials
MAC Opens Phase I Clinic in the Manchester Corridor
Categories
INNOVATION
CORPORATE
EVENTS
AWARDS
MEDIA
REGULATORY
CAREERS
Top
